Key Record Dates Identifier: NCT03365882
Brief Title: S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

First Submitted : October 2, 2017
First Submitted that Met QC Criteria : December 1, 2017
First Posted : December 7, 2017

Last Update Submitted that Met QC Criteria : August 29, 2018
Last Update Posted : August 31, 2018